SCHEMBL21301171

SCHEMBL21301171

CNc1nc(-c2ccc(OC)c(C(F)(F)F)c2)c(CN2CCCC(C(F)(F)F)C2)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMO O15229 1/20 0.40
▸ HTR2A P28223 3/20 0.39
▸ CTSS P25774 2/20 0.38
▸ S1PR1 P21453 1/20 0.37
▸ TRPV4 Q9HBA0 1/20 0.36
▸ ACHE P22303 4/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ PSEN1 P49768 1/20 0.35
▸ PSEN2 P49810 1/20 0.35
▸ APH1B Q8WW43 1/20 0.35
▸ NCSTN Q92542 1/20 0.35
▸ APH1A Q96BI3 1/20 0.35
▸ PSENEN Q9NZ42 1/20 0.35
▸ GRM2 Q14416 1/20 0.34
▸ PDE2A O00408 1/20 0.34
▸ LRRK2 Q5S007 1/20 0.34
▸ MPL P40238 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21300943 0.89 CTSS (0.44) KMOHTR2ACTSSS1PR1TRPV4
SCHEMBL21300945 0.88 KMO (0.49) KMOHTR2ACTSSS1PR1TRPV4
SCHEMBL21301089 0.85 ACHE (0.42) KMOHTR2AS1PR1TRPV4ACHE
SCHEMBL18724169 0.84 MAPT (0.39) KMOHTR2ACTSSS1PR1ACHE
SCHEMBL18724210 0.82 MAPK1 (0.42) KMOHTR2ACTSSS1PR1ACHE
SCHEMBL21301076 0.82 MAPT (0.43) KMOS1PR1ACHEKMT2A
SCHEMBL21301065 0.81 KMO (0.41) KMOCTSSS1PR1TRPV4ACHE
SCHEMBL21300934 0.79 KMO (0.40) KMOHTR2ACTSSS1PR1TRPV4
SCHEMBL17400686 0.79 MPL (0.50) S1PR1TRPV4MPL
SCHEMBL21301082 0.79 HTR2A (0.35) KMOHTR2ACTSSS1PR1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2963036-B1 2-ACYLAMINOTHIAZOLE DERIVATIVE AND SALT THEREOF ASTELLAS PHARMA INC (JP) 2019-08-28 — — EP disclosed
Send feedback